Page 5 - Jane Chao News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jane chao. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jane Chao Today - Breaking & Trending Today
Ceribell Receives FDA Breakthrough Device Designation for Delirium Indication apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Ceribell, Inc., innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced today that Diku Mandavia, MD, has joined. ....
Ceribell, Inc., a Mountain View, CA-based developer of a non-invasive brain monitor, completed a $53m Series C financing. The round was co-led by Longitude Capital and The Rise Fund with participation from new investors RA Capital Management, Redmile Group and Red Tree Venture Capital, with existing shareholders. The company will use the funds to further expand its commercial presence in emergency departments and intensive care units globally. The Ceribell® technology platform is designed to address the need for faster diagnosis in patients with suspicion of seizure. Led by Jane Chao, CEO and Co-Founder, Ceribell provides an FDA cleared, point of care brain monitor that uses real-time cloud computing and the proprietary Clarity™ machine learning algorithm to provide rapid answers at the bedside for immediate and precise treatment. The Ceribell EEG System received FDA 510(k) clearance in 2017 and is commercially available in the United States. ....
Ceribell Announces Completion Of $53 Million Series C Financing Proceeds will be used to expand commercialization of the Ceribell Rapid Response EEG and support pipeline product development to drive future clinical applications News provided by Share this article MOUNTAIN VIEW, Calif., April 29, 2021 /PRNewswire/ Ceribell, Inc., innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced today the completion of a $53 million Series C financing, co-led by Longitude Capital and The Rise Fund. Other new investors include RA Capital Management, Redmile Group and Red Tree Venture Capital, with additional support from existing shareholders. The Ceribell® technology platform is designed to address the need for faster diagnosis in patients with suspicion of seizure. The company will use financing proceeds to further expand Ceribell s commercial footprint in emergency departments and intensive care units globally. In addition, Ceri ....